Retinoblastoma: AJCC Staging Predicts Both Mortality and Globe Salvage
Feb. 17, 2021: AJCC-UICC retinoblastoma staging brings ophthalmic oncology care into the mainstream of world medical oncology and research. Accepted by all other specialties for other cancers, it allows for seamless communication, comparative studies and outcomes research. Herein, Dr. Ankit Tomar represents the AJCC Ophthalmic Oncology Task Force's multicenter, international effort that compared AJCC RB staging to CHLA, WEH and others. Watch this video to better understand how much more functional AJCC retinoblastoma staging can be and how it will improve patients care.